Summary of SGC Q3 2025 Earnings Call

1Key Financial Results and Metrics

Consolidated Revenue: $138 million, down 7% year-over-year.

Branded Products Revenue: $85 million, an 8% decline from $93 million in Q3 2024, impacted by order timing and lower sales volume.

Healthcare Apparel Revenue: $32 million, a 5% decline due to macroeconomic uncertainty.

Contact Center Revenue: $23 million, up 9% but driven by lower volume.

Gross Margin: 38.3%, down from 40.4% year-over-year, consistent with Q2.

SG&A Expenses: Reduced by $4 million to $48 million, maintaining SG&A as a percentage of sales at 35%.

EBITDA: $7.5 million, up sequentially from $6.1 million but down from $11.7 million year-over-year.

Net Income: $2.7 million, up from $1.6 million in Q2 but down from $5.4 million in Q3 2024, resulting in earnings per diluted share of $0.18.

2Strategic Updates and Business Highlights

Cost Management: The company successfully reduced SG&A expenses across all segments while maintaining investment in growth areas.

Branded Products Strategy: Focus on expanding market share through recruiting more sales representatives and leveraging software automation for efficiency.

Healthcare Apparel: Continued investment in demand-driven activities to support brand growth, particularly in direct-to-consumer channels.

Contact Center Pipeline: Strong pipeline with potential new customer conversions despite current challenges.

3Forward Guidance and Outlook

Revenue Outlook: Adjusted full-year revenue guidance to $560 million - $570 million, indicating slight year-over-year growth at the high end.

Q4 Expectations: Anticipated sequential revenue growth primarily driven by the Branded Products segment, with December expected to be the largest month.

4Bad News, Challenges, or Points of Concern

Revenue Declines: All segments reported year-over-year revenue declines, reflecting ongoing macroeconomic uncertainties and customer hesitancy.

Tariff Impact: Continued volatility in trade policies affecting customer behavior and order timing, particularly in the Branded Products segment.

Customer Loss in Contact Center: The loss of a significant customer impacted revenue, with an annualized effect of approximately $2 million.

Gross Margin Pressure: Declines in gross margins across segments due to cost pressures and unfavorable sales mix.

5Notable Q&A Insights

Market Environment: The Branded Products segment is experiencing hesitancy in buying due to tariff-related volatility, but recent positive tariff announcements may stabilize the environment.

Pricing Power: The company has been able to pass through cost increases to customers, particularly in the Branded Products and Healthcare segments.

Acquisition Opportunities: The management sees a rich environment for acquisitions, particularly in the fragmented Branded Products market, with ongoing evaluations of potential targets.

Cost Savings Impact: Approximately half of the $4 million reduction in SG&A expenses was attributed to cost-saving initiatives, with the company on track to achieve $13 million in annualized savings. Overall, SGC is navigating a challenging economic landscape with strategic cost management and a focus on long-term growth, despite facing revenue declines and market uncertainties.